Search results
BIOPHEN Heparin anti-IIa (Kinetics)
Assay proposed for the measurement of heparin in research applications.
BIOPHEN Heparin (anti-Xa, 2-stages kit) -> SEE NEW REF. 221005
Assay proposed for the measurement of anti-Xa heparin activity in research applications. This assay meets USP/EP requirements.
BIOPHEN Heparin (AT+)
Assay proposed for the measurement of heparin in research applications.
BIOPHEN Heparin 6
Measuring the heparin concentration in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin 3
Measuring the heparin concentration in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 3 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 7.5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
β2-Glycoprotein-I EIA
Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.
ZYMUTEST Anti-β2-Glycoprotein IgG
Recurrent unexplained miscarriages. Unexplained lupus anticoagulant, without or with thrombosis. Anti-phospholipid syndrome. Any clinical situation where the assay of anti-β2GP1 auto antibodies is required.
ZYMUTEST β2-Glycoprotein-1 Antigen
Assay proposed for the measurement of β2GP1 antigen in research applications.